These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 26440219)
1. The application of soy isoflavones for subjective symptoms and objective signs of vaginal atrophy in menopause: A systematic review of randomised controlled trials. Ghazanfarpour M; Sadeghi R; Roudsari RL J Obstet Gynaecol; 2016; 36(2):160-71. PubMed ID: 26440219 [TBL] [Abstract][Full Text] [Related]
2. Topical administration of isoflavones for treatment of vaginal symptoms in postmenopausal women: A systematic review of randomised controlled trials. Ghazanfarpour M; Latifnejad Roudsari R; Treglia G; Sadeghi R J Obstet Gynaecol; 2015; 35(8):783-7. PubMed ID: 25710207 [TBL] [Abstract][Full Text] [Related]
3. An overview of the phytoestrogen effect on vaginal health and dyspareunia in peri- and post-menopausal women. Dizavandi FR; Ghazanfarpour M; Roozbeh N; Kargarfard L; Khadivzadeh T; Dashti S Post Reprod Health; 2019 Mar; 25(1):11-20. PubMed ID: 30786797 [TBL] [Abstract][Full Text] [Related]
4. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial. Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055 [TBL] [Abstract][Full Text] [Related]
5. Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis. Franco OH; Chowdhury R; Troup J; Voortman T; Kunutsor S; Kavousi M; Oliver-Williams C; Muka T JAMA; 2016 Jun; 315(23):2554-63. PubMed ID: 27327802 [TBL] [Abstract][Full Text] [Related]
6. Can the use of probiotics in association with isoflavone improve the symptoms of genitourinary syndrome of menopause? Results from a randomized controlled trial. Ribeiro AE; Monteiro NES; Moraes AVG; Costa-Paiva LH; Pedro AO Menopause; 2018 Dec; 26(6):643-652. PubMed ID: 30531444 [TBL] [Abstract][Full Text] [Related]
7. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Krebs EE; Ensrud KE; MacDonald R; Wilt TJ Obstet Gynecol; 2004 Oct; 104(4):824-36. PubMed ID: 15458907 [TBL] [Abstract][Full Text] [Related]
8. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Taku K; Melby MK; Kronenberg F; Kurzer MS; Messina M Menopause; 2012 Jul; 19(7):776-90. PubMed ID: 22433977 [TBL] [Abstract][Full Text] [Related]
9. Effects of sea buckthorn oil intake on vaginal atrophy in postmenopausal women: a randomized, double-blind, placebo-controlled study. Larmo PS; Yang B; Hyssälä J; Kallio HP; Erkkola R Maturitas; 2014 Nov; 79(3):316-21. PubMed ID: 25104582 [TBL] [Abstract][Full Text] [Related]
10. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. Mucci M; Carraro C; Mancino P; Monti M; Papadia LS; Volpini G; Benvenuti C Minerva Ginecol; 2006 Aug; 58(4):323-34. PubMed ID: 16957676 [TBL] [Abstract][Full Text] [Related]
11. The effect of a soy rich diet on the vaginal epithelium in postmenopause: a randomized double blind trial. Chiechi LM; Putignano G; Guerra V; Schiavelli MP; Cisternino AM; Carriero C Maturitas; 2003 Aug; 45(4):241-6. PubMed ID: 12927310 [TBL] [Abstract][Full Text] [Related]
12. Effective treatment of vaginal atrophy with isoflavone vaginal gel. Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487 [TBL] [Abstract][Full Text] [Related]
13. Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials. Taku K; Melby MK; Kurzer MS; Mizuno S; Watanabe S; Ishimi Y Bone; 2010 Aug; 47(2):413-23. PubMed ID: 20452475 [TBL] [Abstract][Full Text] [Related]
14. The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial. Manonai J; Songchitsomboon S; Chanda K; Hong JH; Komindr S Maturitas; 2006 May; 54(2):135-40. PubMed ID: 16297576 [TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women. Liu ZM; Ho SC; Woo J; Chen YM; Wong C Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of isoflavones in relieving vasomotor menopausal symptoms - A systematic review. Jacobs A; Wegewitz U; Sommerfeld C; Grossklaus R; Lampen A Mol Nutr Food Res; 2009 Sep; 53(9):1084-97. PubMed ID: 19653225 [TBL] [Abstract][Full Text] [Related]
17. Comparison of vaginal gel isoflavones versus no topical treatment in vaginal dystrophy: results of a preliminary prospective study. Tedeschi C; Benvenuti C; Gynecol Endocrinol; 2012 Aug; 28(8):652-4. PubMed ID: 22316315 [TBL] [Abstract][Full Text] [Related]
18. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis. Bolaños R; Del Castillo A; Francia J Menopause; 2010; 17(3):660-6. PubMed ID: 20464785 [TBL] [Abstract][Full Text] [Related]
19. [Effect of soy isoflavones on peri-menopausal symptom and estrogen]. Li Y; Liu K; Lei W; Zhang K Wei Sheng Yan Jiu; 2010 Jan; 39(1):56-9. PubMed ID: 20364590 [TBL] [Abstract][Full Text] [Related]
20. Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women. Levis S; Strickman-Stein N; Doerge DR; Krischer J Contemp Clin Trials; 2010 Jul; 31(4):293-302. PubMed ID: 20230914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]